Stay updated on Adagrasib with Nab-Sirolimus in KRAS G12C NSCLC Clinical Trial
Sign up to get notified when there's something new on the Adagrasib with Nab-Sirolimus in KRAS G12C NSCLC Clinical Trial page.

Latest updates to the Adagrasib with Nab-Sirolimus in KRAS G12C NSCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedAn NIH announcement about website terminology appears above the page’s 403 error, and the site revision label changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check33 days agoChange DetectedThe ClinicalTrials.gov page’s displayed site revision changed from v3.7.0 to v3.7.1 while the page continued to show a 403 error.SummaryDifference0.2%

- Check47 days agoChange DetectedThe page now shows a 403 Forbidden error page, and the detailed study record content is no longer visible.SummaryDifference18%

- Check54 days agoChange DetectedPage revision updated from v3.6.6 to v3.7.0, indicating a new version of the site software. This change does not modify the study information visible on the page.SummaryDifference0.1%

- Check68 days agoChange DetectedA new page revision number was added (v3.6.6) replacing the previous (v3.6.5). This indicates an internal update to the page version rather than a change to study information.SummaryDifference0.1%

- Check89 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, indicating a new build of the ClinicalTrials.gov entry.SummaryDifference0.1%

Stay in the know with updates to Adagrasib with Nab-Sirolimus in KRAS G12C NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib with Nab-Sirolimus in KRAS G12C NSCLC Clinical Trial page.